<DOC>
	<DOC>NCT00894517</DOC>
	<brief_summary>This is a 24 week study evaluating the effects of botulinum toxin Type A on semen quality in patients with signs and symptoms of Benign Prostatic Hyperplasia (BPH).</brief_summary>
	<brief_title>A Study Evaluating the Effect of Botulinum Toxin Type A on Semen Quality in Patients With Benign Prostatic Hyperplasia</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Symptoms due to an enlarged prostate Able to provide semen samples at required visits. Previous use of any botulinum toxin for the treatment of any urological condition History of vasectomy History of undescended testicles or testicular trauma Subject who has not ejaculated for greater than 1 year History of prostate infection or any sexually transmitted disease, such as gonorrhea, within the previous 12 months History of bladder stones History of cancer in the prostate, testicles, or bladder Previous use of chemotherapy for cancer treatment History of urinary incontinence Previous prostate surgery</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>